Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species

Cardiovascular Research

Volumn 25, Issue 11, 1991, Pages 943-949

  Goto, Mahiko ^a,b,c   Miura, Tetsuji ^a,b,c   Iliodoromitis, Efstathios K ^a,b,c   O'leary, Edward L ^a,b,c   Ishimoto, Row ^a,b,c   Yellon, Derek M ^a,b,c   Iimura, Osamu ^a,b,c  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Adenosine; Myocardial infarct size; Rabbit; Reperfusion

Indexed keywords

ADENOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; HEART INFARCTION; HEART INFARCTION SIZE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADENOSINE; ANIMAL; BLOOD PRESSURE; COLLATERAL CIRCULATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RABBITS;

EID: 0026091962     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/25.11.943     Document Type: Review

References (25)

1. Olafsson B, Forman MB, Puett D, et al. Reduction of reperfusion injury in the canine preparation by adenosine: Importance of the endothelium and the no-reflow phenomenon. Circulation 1987;76:1135-45.
2. Homeister JW, Hoff PT, Fletcher DD, Lucchesi BR. Combined adenosine and lidocaine administration limit myocardial reperfusion injury. Circulation 1990;82:595-608.
3. Pitarys CJ, Virmani R, Vildibill HD, Jackson EK, Forman MB. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 1991;83:237-47.
4. Norton ED, Jackson EK, Virmani R, Forman MB. Intravenous adenosine limits myocardial reperfusion injury in a model with low myocardial collateral blood flow (abstract). Circulation 1989;80(suppl 2):II-238.
5. Eleseev VV, Krylova IB, Evdokimova NR. Effect of adenosine on the size of experimental myocardial infarction and "no-reflow" areas. Kardiologia 1988;28:98-9.
6. Miura T, Downey JM, Hotta D, Iimura O. Effect of superoxide dismutase plus catalase on myocardial infarct size in rabbits. Can J Cardiol 1988;4:407-11.
7. Miura T, Ogawa S, Ooiwa H, et al. Human superoxide dismutase failed to limit the size of myocardial infarct after 20-, 30-, or 60-minute ischemia and 72-hour reperfusion in the rabbit. Jpn Circ J 1989;53:786-94.
8. Nachlas MM, Schnitka TK. Macroscopic identification of early myocardial infarction by alterations in dehydrogenase activity. Am J Pathol 1963;42:379-405.
9. Heyman MA, Payne BD, Hoffman JIB, Rudolph AM. Blood flow measurements with radionucleotide-labelied particles. Prog Cardiovasc Dis 1977;20:55-79.
10. Mauser M, Hoffmeister HM, Nieber C, Schaper W. Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary occlusion in the dog. Circ Res 1985;56:220-30.
11. Ambrosio G, Jacobus WE, Mitchell MC, Litt MR, Becker LC. Effects of ATP precursors on ATP and free ADP content and functional recovery of postischemic hearts. Am J Physiol 1989;256:H560-6.
12. Kitakaze, Takashima S, Sato H. Stimulation of adenosine A1 and A2 receptors prevent myocardial stunning (abstract). Circulation 1990;82(suppl 3):III-37.
13. Ogawa T, Miura T, Iwamoto T, Adachi T, Ooiwa H, Iimura O. Intravenous administration of adenosine attenuates myocardial stunning in the rabbit heart (abstract). J Mol Cell Cardiol 1991;23(suppl 2):S31.
14. Nathan HJ, Feigl EO. Adrenergic vasoconstriction lessens transmural steal during coronary hypoperfusion. Am J Physiol 1986;250:H645-53.
15. McFalls EO, Pantely GA, Anselone CG, Bristow DJ. Importance of vasomotor tone to myocardial function and regional metabolism during constant flow ischemia. Cardiovasc Res 1990;21:813-20.
16. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1969.
17. Chambers DE, Parks DA, Patterson G, et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145-52.
18. Downey JM, Miura T, Eddy LJ, et al. Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol 1987;19:1053-60.
19. Charlat ML, O'Neill PG, Egan JM, et al. Evidence for a pathogenic role of xanthine oxidase in the "stunned" myocardium. Am J Physiol 1987;252:H566-77.
20. Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of "stunned" myocardium. Circ Res 1986;58:148-56.
21. Matuski T, Cohen MV, Downey JM. Free-radical scavengers preserve wall motion in the xanthine oxidase-deficient rabbit heart. Coronary Artery Dis 1990;1:383-9.
22. Adachi T, Miura T, Noto T, et al. Does verapamil limit myocardial infarct size in a heart deficient in xanthine oxidase? Clin Exp Pharmacol Physiol 1990;17:769-79.
23. Reimer KA, Jennings RB. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Lab Invest 1984;51:655-66.
24. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Preconditioning protection is mediated by Al adenosine receptors in the rabbit heart (abstract). FASEBJ 1991;5:A1050.
25. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous Al selective adenosine agonists limit infarct size in the rabbit heart (abstract). FASEB J 1991;5:A1104.